Ultralife Corporation
ULBI
$7.10
$0.162.31%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 93.92% | -508.36% | -238.79% | -52.87% | 861.34% |
| Total Depreciation and Amortization | 1.07% | -7.89% | 0.07% | 4.65% | 14.93% |
| Total Amortization of Deferred Charges | 0.00% | 0.00% | -2.94% | 4.62% | 38.30% |
| Total Other Non-Cash Items | -103.59% | 3,622.46% | -156.21% | -16.07% | 69.08% |
| Change in Net Operating Assets | 176.42% | -1,144.98% | -93.21% | 713.35% | -139.22% |
| Cash from Operations | 51.51% | 652.02% | -96.66% | 76.22% | 10.57% |
| Capital Expenditure | 12.70% | 11.36% | 9.55% | -22.91% | -47.69% |
| Sale of Property, Plant, and Equipment | -- | -200.00% | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 13.09% | 10.60% | 9.91% | -22.91% | 98.16% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -200.29% | 0.15% | 74.40% | -291.27% | 91.45% |
| Issuance of Common Stock | -- | -100.00% | -39.34% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 100.00% | -- | -- |
| Cash from Financing | -200.29% | -5.53% | 75.44% | -285.88% | -101.50% |
| Foreign Exchange rate Adjustments | -27.81% | 171.31% | -723.68% | -51.90% | 538.89% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -635.29% | 105.06% | -175.65% | 19.14% | 2,231.25% |